Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Endocrinology
•
Adrenal Disorders
Would you recommend testing for adrenal dysfunction in a euvolemic and hypertensive patient on anti-hypertensive therapy presenting with combined hyperkalemia and hyponatremia?
Related Questions
Does Entresto interfere with the measurement of ARR (Aldosterone to Renin Ratio) when working up a patient for hyperaldosteronism?
What 60 minute cortisol threshold value do you use for diagnosis of adrenal insufficiency after ACTH stimulation?
Can 24-hour urine aldosterone levels be used to screen for primary aldosteronism in a patient taking finerenone?
Do you recommend combined baseline cortisol and DHEA-S testing to improve the efficiency and accuracy of adrenal insufficiency diagnosis?
Would you expect an oral sodium loading test to be positive in secondary hyperaldosteronism or pseudohyperaldosteronism?
Do progesterone only oral contraceptive pills affect cortisol binding globulin?
Do patients with central adrenal insufficiency on maintenance hydrocortisone therapy require doubling of their corticosteroid during chemotherapy cycles?
Is adequate BP control sufficient enough when titrating spironolactone therapy for primary hyperaldosteronism treatment?
In ischemic stroke patients with low LDL levels (<30-50 mg/dl), would you consider lowering LDL levels to lower values without concern for any side effects?
How should clinicians balance the use of finerenone with other heart failure treatments like SGLT2 inhibitors, considering their glycemic benefits?
